Terrascend Corp. (TSNDF)
0.6142
-0.02
(-2.87%)
USD |
OTCM |
Jan 30, 15:59
Terrascend EPS Diluted (Quarterly) : -0.0841 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4072 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.907M |
| Revenue (Quarterly) | 65.10M |
| Total Expenses (Quarterly) | 76.21M |
| Enterprise Value | 411.78M |
| Gross Profit Margin (Quarterly) | 49.87% |
| Profit Margin (Quarterly) | -15.22% |
| Earnings Yield | -65.79% |
| Operating Earnings Yield | 20.24% |
| Normalized Earnings Yield | -48.84 |